Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stress Disorders, Post-Traumatic 2Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obsessive-Compulsive Disorder 1Neoplasms 1Melanoma, Cutaneous Malignant 1Anxiety Disorders 1

Interventions

Magnetic Resonance Spectroscopy 17Iodine-131 16lenvatinib 13trametinib 12Thyrotropin Alfa 11Sorafenib 11pembrolizumab 10dabrafenib 10Paclitaxel 9vandetanib 8Thyroxine 8Surgical Procedures, Operative 7Sunitinib 7selpercatinib 6cabozantinib 6Nivolumab 6Fluorodeoxyglucose F18 6Everolimus 6pazopanib 5Vemurafenib 5Thyroidectomy 5Specimen Handling 5Saline Solution 5Radiotherapy 5Radiofrequency Ablation 5Cyclophosphamide 5Cisplatin 5Biopsy 5apatinib 4anlotinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thyroid Neoplasms × Eye Movement Desensitization Reprocessing × Clear all
NCT07447089 2026-03-04

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Università Cattolica di Milano

Phase NA Recruiting
25 enrolled
Head & Neck

Neoplasms, Stress Disorders, Post-Traumatic, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡